Cortical Source Multivariate EEG Synchronization Analysis on Amnestic Mild Cognitive Impairment in Type 2 Diabetes

Table 1

Demographic characteristics and neuropsychological test scores and values between aMCI and control groups in T2DM.

Factor	aMCI group	Control group	value
Subjects	8	11	—
Gender (M/F)	5/3	5/6	—
Age (years)	70 ± 10.784	74.27 ± 3.349	NS
Education level (years)	13.88 ± 3.441	13.64 ± 2.541	NS
MMSE scores	26.88 ± 1.885	28.64 ± 0.674	0.034*
MOCA scores	22 ± 1.852	27 ± 1.265	0.000**
AVLT immediate recall	5.06 ± 1.664	7.78 ± 1.859	0.004**
AVLT delayed recall	3.75 ± 3.105	8.82 ± 3.683	0.005**
AVLT delay recognition	11 ± 3.117	13.91 ± 1.044	0.034*
Boston Name Test	18.38 ± 1.188	19.82 ± 0.405	0.011*
Semantic fluency	16.88 ± 3.314	18.18 ± 4.07	0.452
Trail Making test A	68.5 ± 19.878	60.64 ± 16.549	0.36
Trail Making test B	127.5 ± 62.551	102.91 ± 34.469	0.286
WAIS digit span test	11.5 ± 3.854	14.73 ± 2.24	0.034*
IADL	1.13 ± 1.356	0.45 ± 1.508	0.333

Mean values ± standard errors of demographic characteristics and neuropsychological test scores in aMCI and control groups. values were obtained comparing aMCI and control groups with independent samples -test.
aMCI, amnestic mild cognitive impairment; AVLT, the Auditory Verbal Learning Test; F, female; IADL, Instrumental Activity of Daily Living Scale; M, male; MMSE, Mini-Mental State Examination; MOCA, Montreal Cognitive Assessment; NS, not significant; WAIS, Wechsler Adult Intelligence Scale; *indicates the value < 0.05; **indicates the value < 0.01.